Medinotec (MDNC) Current Deferred Revenue (2023)
Medinotec's (MDNC) quarterly Current Deferred Revenue came in at $64640.0 in Q4 2023, up 26.32% quarter-over-quarter from $51170.0 in Q3 2023.
Powered by 
Analysis
Medinotec (MDNC) Current Deferred Revenue (2023) Analysis & Trends
Medinotec (MDNC) has reported Current Deferred Revenue for 1 consecutive years, with $64640.0 the latest figure, recorded in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn |